Le produit a bien été ajouté au panier.

discount label
H-VWLSVIWM-OH
Vue en 3D

Biosynth logo

H-VWLSVIWM-OH

Ref. 3D-PP48564

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-VWLSVIWM-OH
Description :

Peptide H-VWLSVIWM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VWLSVIWM-OH include the following: Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice Z Qi, G Li, H Hu , C Yang, X Zhang, Q Leng - Journal of , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01024-14 The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model Z Ma, J Liu, W Wu, E Zhang , X Zhang, Q Li - Cellular & molecular , 2017 - nature.comhttps://www.nature.com/articles/cmi201743 Recombinant Covalently Closed Circular Y Gao, K Lan, Q Deng, QL Zhang, Y Xie, D Yu, X Zhang - J. Virol, 2014 - academia.eduhttps://www.academia.edu/download/44061139/Recombinant_Covalently_Closed_Circular_H20160324-30626-1qn6viw.pdf Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model Y Bu, K Zhao, Z Xu, Y Zheng, R Hua, C Wu, C Zhu - Virologica Sinica, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1995820X23000482 HBsAg-specific CD8+ T cells as an indispensable trigger to induce murine hepatocellular carcinoma X Hao , Y Chen, L Bai , H Wei, R Sun - Cellular & molecular , 2021 - nature.comhttps://www.nature.com/articles/s41423-019-0330-1 A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X TH Kingl - S and Core Specific T Cells in Mice and Activates , 2014 - academia.eduhttps://www.academia.edu/download/89859031/f142b96de8e26e56244e549779a6a66d9a01.pdf A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to TH King, CB Kemmler , Z Guo, D Mann, Y Lu - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101904 WHOLE RECOMBINANT YEAST THERAPEUTIC VACCINE GENERATES HBV X, S, AND CORE ANTIGEN-SPECIFIC RESPONSES IN MURINE AND HUMAN TH King, AJ Gehring , A Bertoletti , ZZ Ho - Journal of , 2013 - globeimmune.comhttp://globeimmune.com/wp-content/uploads/2012/04/King_EASL_2013_HBV_4-25-13.pdf Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity S Zeissig , K Murata, L Sweet, J Publicover, Z Hu - Nature medicine, 2012 - nature.comhttps://www.nature.com/articles/nm.2811 Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen R Schirmbeck, W Böhm, N Fissolo - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324125 Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T R Schirmbeck, P Riedl, R Zurbriggen - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/171/10/5198/1831 Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants R Schirmbeck, N Dikopoulos, M Kwissa - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324403 Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice P Bochtler, C Wahl, R Schirmbeck - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/12/8307/74015 Regulatory mechanisms in immune responses P Bochtler - 2016 - oparu.uni-ulm.dehttps://oparu.uni-ulm.de/items/3327a214-8225-43b3-9212-68bdb90d21dc Novel peptide-based vaccines efficiently prime murine"help"-independent CD8+ T cell responses in the liver N Dikopoulos, P Riedl, R Schirmbeck, J Reimann - Hepatology, 2004 - Wiley Online Libraryhttps://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.20330 Specific, functional effector/memory CD8+ T cells are found in the liver post-vaccination N Dikopoulos, I Jomantaite, R Schirmbeck - Journal of , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168827803004690 Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells N Dikopoulos, A Bertoletti , A Kröger - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/1/99/72273 NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner MO Diniz, A Schurich, SK Chinnakannan - Science Translational , 2022 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.abi4670 A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice MA Cobleigh, X Wei , MD Robek - Journal of virology, 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02111-12 Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice L Zong, H Peng, C Sun , F Li , M Zheng, Y Chen - Nature , 2019 - nature.comhttps://www.nature.com/articles/s41467-018-08096-8 Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses L Cao , C Wu, H Shi, Z Gong, E Zhang, H Wang - Journal of , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01123-14 Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model G Li, Y Zhu, D Shao, H Chang, X Zhang, D Zhou - , 2018 - Wiley Online Libraryhttps://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29406 A mouse model for HBV immunotolerance and immunotherapy D Yang, L Liu , D Zhu, H Peng, L Su, YX Fu - Cellular & molecular , 2014 - nature.comhttps://www.nature.com/articles/cmi201343 Evaluation of antiviral-passive-active immunization ("œsandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice B Shi, Y Wu, C Wang, X Li, F Yu, B Wang, Z Yang - , 2019 - thelancet.comhttps://www.thelancet.com/article/S2352-3964(19)30713-3/fulltext

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP48564 H-VWLSVIWM-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".